Friday 17 September 2021

Costa Rica’s Clodomiro Picado Institute Tests First Batches of Drug Against COVID-19

Paying the bills

Latest

500 Intel drones illuminated the night of celebration of the Bicentennial of Costa Rica

QCOSTARICA - During the celebration of the Bicentennial of...

Covid-19 contagion rate drops, but hospitals still under pressure

QCOSTARICA - The contagion rate of covid-19 once again...

More than 1.1 million vaccines against covid-19 have been received so far in September

QCOSTARICA - With the arrival of 157,950 doses of...

Chile reopens borders to visitors ahead of summer tourism season

Q24N - SANTIAGO (Reuters) - Chile announced plans to...

Chile among the 5 countries that are opening up and living with Covid

Q REPORTS - London (CNN) - More than 18...

Why buy a flat in Dubai

Investing and getting a good income is one of...

Today’s Vehicle Restriction September 17: Plates ending in “9 & 0” CANNOT circulate

QCOSTARICA - For today, Friday, September 17, vehicles with...
Paying the bills

Share

(QCOSTARICA) The first two batches of a potential drug to treat COVID-19 produced by the Clodomiro Picado Institute of the University of Costa Rica (ICP-UCR) are ready for quality control tests.

The treatment was obtained through the inoculation of proteins against the virus in horses, from which a product known as equine immunoglobulins (antibodies) was obtained.

- Advertisement -

The batches consist of a total of 1,000 injection bottles and contain antibodies against two different combinations of proteins from SARS-CoV-2, the virus that causes COVID-19.

If this drug were to prove safe and effective, it would be used as a serum in people who are hospitalized with COVID-19. This is one of the three options in which the ICP-UCR works together with the Caja Costarricense de Seguro Social (CCSS). The other two are using plasma from recovered patients, and purifying this plasma and creating specific sera with the antibodies found in the plasma.

At the moment, the data on the equine immunoglobulins already register good results.

“The previous data we have indicate that the formulations comply with the design that we had established,” said Guillermo León Montero, coordinator of the Industrial Division of ICP-UCR.

At this time, the formulations are undergoing quality control tests. One of them is the so-called sterility test, which aims to ensure that this serum is safe for patients.

After this step, it can be sent to the CCSS for use in patients with COVID-19.

- Advertisement -

The studies are being carried out by the Pharmaceutical Analysis and Advisory Laboratory of the Faculty of Pharmacy of the UCR (Layafa-UCR).

“This quality test seeks to demonstrate the safety of the product in terms of verifying the absence of aerobic bacteria, fungi, and yeasts.

“The test is very important because, if a product with some contamination is applied to the patient, it can produce sepsis and endanger their life,” said Jeimy Blanco Barrantes, coordinator of the Laboratory.

Quality control is not the only exam that this product must pass.

- Advertisement -

In the United States, the George Mason University is analyzing whether the formulations proposed by Costa Rican scientists inhibit the infectious power of the SARS-CoV-2 virus in culture cells.

If the test is passed, the ICP-UCR will send the formulations to the CCSS, which will carry out a clinical study to conclusively determine if the formulations made are effective and safe for the treatment of patients with COVID-19.

“The formulations have high concentrations of antibodies against viral proteins. In fact, they have significantly higher concentrations than the plasma of convalescent patients. However, only the clinical study will tell if the formulations are effective, “emphasized León.

- Advertisement -
Paying the bills
Ricohttp://www.theqmedia.com
"Rico" is the crazy mind behind the Q media websites, a series of online magazines where everything is Q! In these times of new normal, stay at home. Stay safe. Stay healthy.

Related Articles

Covid-19 contagion rate drops, but hospitals still under pressure

QCOSTARICA - The contagion rate of covid-19 once again presented a...

More than 1.1 million vaccines against covid-19 have been received so far in September

QCOSTARICA - With the arrival of 157,950 doses of the vaccine...

Subscribe to our stories

To be updated with all the latest news, offers and special announcements.

Log In

Forgot password?

Forgot password?

Enter your account data and we will send you a link to reset your password.

Your password reset link appears to be invalid or expired.

Log in

Privacy Policy

Add to Collection

No Collections

Here you'll find all collections you've created before.